This trial is enrolling 100 participants with chronic spinal cord injury to test the effect of a wearable transcutaneous neuromodulation (TNM) device on bowel health. TNM is a non-invasive electrical stimulation technique that delivers low-level current through surface electrodes on the skin to modulate nerve activity and influence organ or muscle function. If included, participants will be randomly assigned to self-administer either active or sham TNM twice daily for 4 weeks. Participants in the sham group may opt into an additional 2-week active TNM phase. Final testing of bowel function will be performed after 4 weeks.
Non-traumatic
Traumatic
Type
Details
- Participants will be randomly assigned to self-administer either active or sham transcutaneous neuromodulation (TNM) twice daily for 4 weeks. - TNM is a non-invasive electrical stimulation technique that delivers low-level current through surface electrodes on the skin to modulate nerve activity and influence organ or muscle function. - After unblinding, participants in the sham group may opt into an additional 2-week active TNM phase. - Final testing of bowel function will be performed after 4 weeks.
Main benefits
General health
Additional benefits
Bowel health
Mental health and psychosocial factors
Sensory function
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more